Search Results 351-360 of 17005 for citrulline loading phase

  1. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

    In Part 1 of Arm A, participants will receive MK-8242 monotherapy in escalating doses to determine the recommended phase 2 dose [RP2D]. In Part 2, participants ...

  2. A Study Evaluating the Long-Term Effectiveness and Safety of Ralinepag in Subjects with PAH Via an Open-Label Extension - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Midodrine Hydrochloride in Early Sepsis - Clinical Trials

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study Of Crohn's Disease Patient Symptoms During Ingestion Of Oral Contrast For CT Or MR Enterography And Morphologic - Mayo Clinic

    ... phase with the patient Crohn's imaging findings in the scan clinical report. Participation eligibility. Participant eligibility includes age, gender, type ...

  5. A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Open-Label Extension Study of Setmelanotide - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. Pilot Study Of Duodenal Mucosal RF Vapor Ablation In US Subjects With Type-2 Diabetes Mellitus - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Study Of BLU-808 In Chronic Inducible Urticaria (CIndU) And Chronic Spontaneous Urticaria (CSU) - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Clinical trials - Oncology (Medical)

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...